Ghost Tree Capital, LLC Sage Therapeutics, Inc. Call Options Transaction History
Ghost Tree Capital, LLC
- $267 Million
- Q3 2024
Call Options
2 transactions
Others Institutions Holding SAGE
# of Institutions
189Shares Held
42MCall Options Held
301KPut Options Held
157K-
Black Rock Inc. New York, NY5.22MShares$37.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.84MShares$34.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.59MShares$32.8 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.46MShares$31.8 Million0.48% of portfolio
-
Rtw Investments, LP New York, NY3MShares$21.4 Million0.27% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $424M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...